首页> 外文OA文献 >Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

【2h】

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

机译：Abatacept或英夫利昔单抗与安慰剂在ATTEST中的疗效和安全性：类风湿关节炎患者对甲氨蝶呤反应不足的III期，多中心，随机，双盲，安慰剂对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Schiff, M; Keiserman, M; Codding, C; Songcharoen, S; Berman, A; Nayiager, S; Saldate, C; Li, T; Aranda, R; Becker, J-C; Lin, C; Cornet, P L N; Dougados, M;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. [J] . Schiff M, Keiserman M, Codding C, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2008,第8期

机译：阿巴西普或英夫利昔单抗与安慰剂在ATTEST中的疗效和安全性：类风湿关节炎患者对甲氨蝶呤反应不足的III期，多中心，随机，双盲，安慰剂对照研究。
2. Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan [J] . Takeuchi Tsutomu, Tanaka Yoshiya, Tanaka Sakae, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第10期

机译：PEFICITINIB（ASP015K）在类风湿性关节炎患者中的疗效和安全性和对甲氨蝶呤的不足：日本III期随机，双盲，安慰剂对照试验（RAJ4）的结果
3. Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study [J] . Bi L., Li Y., He L., Clinical and experimental rheumatology . 2019,第2期

机译：Certolizumab Pegol与甲氨蝶呤在甲氨蝶呤 - 不足的响应者中的抑制剂的疗效和安全性 - 活性类风湿性关节炎患者：24周的随机，双盲，安慰剂控制第3期研究
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III multi-centre randomised double-blind placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate [O] . M Schiff, M Keiserman, C Codding, -1

机译：Abatacept或英夫利昔单抗与安慰剂在ATTEST中的疗效和安全性：类风湿关节炎患者对甲氨蝶呤反应不足的III期多中心随机双盲安慰剂对照研究
7. Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan [O] . Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka, 2019

机译：PEFICITINIB（ASP015K）对类风湿性关节炎患者的疗效和安全性和对甲氨蝶呤的不足：日本III期随机，双盲，安慰剂对照试验（RAJ4）的结果

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

著录项

相似文献

相关主题

期刊订阅